Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease — Stella
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations(27 sites)
United States
Palo Alto VA Medical Center, Palo Alto, California
China
Fuwai Hospital, Chinese Academy of Medical Sciences (CAMS), Beijing
Second Affiliated Hospital of Zhejiang University School of Medicine, Hanzhou
India
Medanta - The Medicity, Gurugram
Fortis Escorts Heart Institute, New Delhi
Malaysia
Sarawak Heart Centre, Kota Samarahan
Serbia
University Clinical Center of Serbia, Belgrade
Singapore
National Heart Centre Singapore (NHCS), Singapore
South Korea
Daegu Catholic University Medical Center, Daegu
Keimyung University Dongsan Medical Center, Daegu
Yeungnam University Medical Center, Daegu
Chungnam National University Hospital, Daejeon
Konyang University Hospital, Daejeon
Gangneung Asan Hospital, Gangneung
Chonnam National University Hospital, Gwangju
National Health Insurance Service Ilsan Hospital, Ilsan
Gachon University Gil Hospital, Incheon
Dong-A Medical Center, Pusan
Asan Medical Center, Seoul
Hanyang University Seoul Hospital, Seoul
Samsung Medical Center, Seoul
Taiwan
National Taiwan University Hospital, Taipei
Thailand
Siriraj Hospital, Bangkok
SNU Boramae Medical Center, Seoul
The Catholic University of Korea, St. Vincent's Hospital, Suwon
The Catholic University of Korea, Uijeongbu ST. Mary's Hospital, Uijeongbu-si